Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients with intermediate risk (IR) and high-intermediate risk (HIR) endo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Gynecol Oncol
Autori principali: Reboux, Pierre-Alain, Azaïs, Henri, Canova, Charles-Henry, Bendifallah, Sofiane, Ouldamer, Lobna, Raimond, Emilie, Hudry, Delphine, Coutant, Charles, Graesslin, Olivier, Touboul, Cyril, Collinet, Pierre, Bricou, Alexandre, Huchon, Cyrille, Daraï, Emile, Ballester, Marcos, Lévêque, Jean, Lavoué, Vincent, Koskas, Martin, Uzan, Catherine, Canlorbe, Geoffroy
Natura: Artigo
Lingua:Inglês
Pubblicazione: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543117/
https://ncbi.nlm.nih.gov/pubmed/31074238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2019.30.e53
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi